INSIGHTS ON CLINICAL TRIAL PARTNERING
-
![GettyImages-1441381006 budget talks]( "The Hidden Cost Of Transactional Burden: It's Time For Sites To Speak Up")
The Hidden Cost Of Transactional Burden: It's Time For Sites To Speak UpTransactional burdens weigh heavily on sites, straining trust with sponsors and patients. See why site voices matter and how sounding off can strengthen clinical trial relationships.
-
![clinical-trial-tech-ai-GettyImages-2226144959]( "The Agentic AI Readiness Myths Costing Sponsors Time")
The Agentic AI Readiness Myths Costing Sponsors TimeMany clinical organizations believe they must clean data and unify systems before adopting agentic AI. New approaches show teams can start now, create value faster, and improve readiness as they scale.
-
![Delivering value in clinical trial logistics]( "Scalable Strategies For Delivering Value In Clinical Trial Logistics")
Scalable Strategies For Delivering Value In Clinical Trial LogisticsDiscover how to transform logistical challenges into strategic advantages with flexible, forward-looking solutions designed for today’s dynamic clinical development landscape.
-
![clinical-trial-operations-GettyImages-1488780488]( "Make GCP Training Easier For Sites Before Meetings")
Make GCP Training Easier For Sites Before MeetingsCompleting GCP training before investigators’ meetings reduces compliance work, aligns site expectations, and frees meeting time for protocol planning and study startup preparation.
-
Site Engagement Doesn't Start At First Patient In7/15/2025
Site engagement starts long before enrollment. Explore how well-designed investigator meetings can set the tone, build trust, and give site teams the momentum they need to deliver.
-
Innovative Approaches In Oncology Clinical Trials2/6/2025
By embracing innovative trial models and strategic collaborations, oncology CROs play a pivotal role in bringing novel cancer therapies to market efficiently and effectively.
-
From First-In-Human To Proof-Of-Concept — Quicker, Smarter, Streamlined10/14/2025
Explore examples of smarter SAD/MAD trial designs including multi-part and hybrid protocols, regulatory foresight, recruitment considerations, and operational strategies that keep programs moving.
-
Finding The Right CRO Partner For Early-Stage Oncology Trials11/21/2025
Discover how a data-driven CRO selection framework can replace manual processes, minimize bias, and build stronger, more collaborative sponsor–vendor relationships.
-
Debunking 5 Misconceptions About Community-Based Research Sites5/28/2025
By confronting misconceptions about community-based research, we uncover evidence of how sites effectively manage complex trials while maintaining high standards of care.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
![GettyImages-1180547354 clinical trial tablet research]( "Full Service CRO And Regulatory Partner For Biologics")
Advancing biologics from start to finish is highly complex and full of challenges, requiring scientific strategies and implementation.
-
![doctor clinical trial meeting iStock-986569806]( "Full-Service Clinical Development Solutions")
Getting a novel therapy through the clinical development process to approval is complicated. Unearth how to advance novel medical therapies from Phase I-III clinical development to market with confidence.
-
![clinical-drug-development-GettyImages-1354172647]( "Drug Safety And Pharmacovigilance Services")
Navigating drug safety in the era of innovation-driven medicine
The focus on drug safety and pharmacovigilance has never been more intense. Patient safety remains paramount throughout a product's lifecycle, even as sponsors and marketing authorization holders (MAHs) face increasing complexity in managing safety data. This complexity stems from huge volumes of data generated from scores of diverse sources, much of it rapidly expanding unstructured data. Innovation-driven medicine is a key factor. These dynamics are reshaping the landscape of drug safety, presenting both challenges and opportunities for innovation in pharmacovigilance practices.
-
![GettyImages-966266114 CRA]( "Rave TSDV - Improve CRA Efficiency And Reduce Site Burden")
Source data verification (SDV) is a critical activity within clinical trial monitoring, yet the traditional approach focused on 100% SDV is limited in its ability to quickly identify issues and prevent them from recurring. Rave TSDV (Targeted SDV), unified with Rave EDC, enables CRAs to focus on critical to quality (CtQ) factors identified within risk management activities.
-
![clinical-sites-GettyImages-2057440780]( "A Premier Site Network For High-Performance Trials")
A national research network with advanced facilities, expert investigators, and diverse patients to support efficient Phase I–IV trials and speed complex protocols and enrollment.
